ResMed Total Assets from 2010 to 2026

RME Stock  EUR 214.00  1.10  0.52%   
ResMed's Total Assets are increasing over the last several years with slightly volatile swings. Total Assets are predicted to flatten to about 5 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2017-03-31
Previous Quarter
8.3 B
Current Value
8.5 B
Quarterly Volatility
1.6 B
 
Covid
 
Interest Hikes
Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Interest Expense of 55.2 M, Selling General Administrative of 741.1 M or Total Revenue of 3.3 B, as well as many indicators such as . ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
  
This module can also supplement various ResMed Technical models . Check out the analysis of ResMed Correlation against competitors.
The Total Assets trend for ResMed Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ResMed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest ResMed's Total Assets Growth Pattern

Below is the plot of the Total Assets of ResMed Inc over the last few years. Total assets refers to the total amount of ResMed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ResMed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. ResMed's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 8.17 B10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

ResMed Total Assets Regression Statistics

Arithmetic Mean4,479,104,504
Geometric Mean4,024,264,673
Coefficient Of Variation49.10
Mean Deviation1,739,681,357
Median4,107,682,000
Standard Deviation2,199,129,028
Sample Variance4836168.5T
Range7.2B
R-Value0.88
Mean Square Error1195443.7T
R-Squared0.77
Slope381,711,318
Total Sum of Squares77378695.7T

ResMed Total Assets History

2026B
20259.4 B
20248.2 B
20236.9 B
20226.8 B
20215.1 B
20204.7 B

About ResMed Financial Statements

ResMed stakeholders use historical fundamental indicators, such as ResMed's Total Assets, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets9.4 BB

Currently Active Assets on Macroaxis

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out the analysis of ResMed Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
It's important to distinguish between ResMed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ResMed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, ResMed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.